FI116035B - Menetelmä sokeripäällysteisen farmaseuttisen annosyksikön valmistamiseksi - Google Patents

Menetelmä sokeripäällysteisen farmaseuttisen annosyksikön valmistamiseksi Download PDF

Info

Publication number
FI116035B
FI116035B FI946043A FI946043A FI116035B FI 116035 B FI116035 B FI 116035B FI 946043 A FI946043 A FI 946043A FI 946043 A FI946043 A FI 946043A FI 116035 B FI116035 B FI 116035B
Authority
FI
Finland
Prior art keywords
steroid
sugar
desogestrel
tablet
granule
Prior art date
Application number
FI946043A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI946043A0 (fi
FI946043A (fi
Inventor
Haan Pieter De
Marcus Johannes Maria Deurloo
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of FI946043A0 publication Critical patent/FI946043A0/fi
Publication of FI946043A publication Critical patent/FI946043A/fi
Application granted granted Critical
Publication of FI116035B publication Critical patent/FI116035B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI946043A 1993-12-23 1994-12-22 Menetelmä sokeripäällysteisen farmaseuttisen annosyksikön valmistamiseksi FI116035B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93203645 1993-12-23
EP93203645 1993-12-23

Publications (3)

Publication Number Publication Date
FI946043A0 FI946043A0 (fi) 1994-12-22
FI946043A FI946043A (fi) 1995-06-24
FI116035B true FI116035B (fi) 2005-09-15

Family

ID=8214236

Family Applications (1)

Application Number Title Priority Date Filing Date
FI946043A FI116035B (fi) 1993-12-23 1994-12-22 Menetelmä sokeripäällysteisen farmaseuttisen annosyksikön valmistamiseksi

Country Status (16)

Country Link
US (1) US5662936A (de)
EP (1) EP0659432B1 (de)
JP (1) JPH07206681A (de)
KR (1) KR100330560B1 (de)
CN (1) CN1108929A (de)
AT (1) ATE155039T1 (de)
AU (1) AU685538B2 (de)
CA (1) CA2138451C (de)
DE (2) DE69404116T2 (de)
DK (1) DK0659432T3 (de)
ES (1) ES2105501T3 (de)
FI (1) FI116035B (de)
GR (1) GR3024817T3 (de)
NO (1) NO305273B1 (de)
NZ (1) NZ270228A (de)
ZA (1) ZA949929B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
EP0792152B1 (de) * 1994-11-22 2004-04-14 Balance Pharmaceuticals, Inc. Verfahren zur empfängnisverhütung
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
ATE195871T1 (de) * 1997-09-23 2000-09-15 Akzo Nobel Nv Steroid enthaltende dosierungsformen mit einer steroiddichten umhüllung
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
NZ517799A (en) * 1999-10-11 2003-09-26 Ml Lab Plc Medicament delivery device with moisture resistant coating
US6254888B1 (en) 2000-01-28 2001-07-03 Boehringer Ingelheim Pharmaceuticals, Inc. Method for coating pharmaceutical dosage forms
US20030104066A1 (en) * 2000-03-27 2003-06-05 Kouji Murai Easy-to-take granules
ES2257412T3 (es) * 2000-05-18 2006-08-01 Therics, Inc. Encapsulacion de un nucleo toxico en una region no toxica en una forma de dosificacion oral.
JP2002068965A (ja) * 2000-08-31 2002-03-08 Teikoku Hormone Mfg Co Ltd 単層糖衣錠及びその製造方法
AU2002220248A1 (en) * 2000-11-06 2002-05-15 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US7303763B2 (en) * 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
CA2562386C (en) 2004-04-21 2014-11-18 Innovata Biomed Limited Inhaler
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
DE602005023193D1 (de) * 2004-10-15 2010-10-07 Suedzucker Ag Verbessertes trommelcoating-verfahren
JP4808453B2 (ja) * 2005-08-26 2011-11-02 株式会社荏原製作所 研磨方法及び研磨装置
WO2007035961A2 (en) * 2005-09-23 2007-03-29 Threshold Pharmaceuticals, Inc. Anti-cancer therapies
BR112013016376A2 (pt) * 2010-12-29 2018-06-19 Nestec S.A. produto de confeitos compreendendo pó de óleo aglomerado
IN2014DN10980A (de) * 2012-07-03 2015-09-18 Nestec Sa
EP2922907A1 (de) * 2012-11-22 2015-09-30 Evonik Röhm GmbH Verfahren zur herstellung eines granulierter produkts aus einer pulverförmigen zusammensetzung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2736682A (en) * 1954-10-11 1956-02-28 Victor M Hermelin Method of making a prolonged action medicinal tablet
US3576663A (en) * 1967-05-29 1971-04-27 Colorcon Coated tablet
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations

Also Published As

Publication number Publication date
DE659432T1 (de) 1997-01-30
DE69404116T2 (de) 1997-11-13
AU685538B2 (en) 1998-01-22
CA2138451C (en) 2007-04-24
ATE155039T1 (de) 1997-07-15
KR100330560B1 (ko) 2002-09-05
AU8168494A (en) 1995-06-29
DE69404116D1 (de) 1997-08-14
NO944991L (no) 1995-06-26
CN1108929A (zh) 1995-09-27
ZA949929B (en) 1995-08-23
US5662936A (en) 1997-09-02
GR3024817T3 (en) 1998-01-30
NO944991D0 (no) 1994-12-22
KR950016715A (ko) 1995-07-20
CA2138451A1 (en) 1995-06-24
EP0659432A1 (de) 1995-06-28
EP0659432B1 (de) 1997-07-09
NZ270228A (en) 1995-09-26
FI946043A0 (fi) 1994-12-22
JPH07206681A (ja) 1995-08-08
ES2105501T3 (es) 1997-10-16
NO305273B1 (no) 1999-05-03
DK0659432T3 (da) 1998-02-16
FI946043A (fi) 1995-06-24

Similar Documents

Publication Publication Date Title
FI116035B (fi) Menetelmä sokeripäällysteisen farmaseuttisen annosyksikön valmistamiseksi
AU2005202046B9 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
AU2007271449B2 (en) Pharmaceutical composition containing a tetrahydrofolic acid
JP2011157401A (ja) 結合型エストロゲンのための組成物および関連方法
US20030099710A1 (en) Granule modulating hydrogel system
AU2002361396B2 (en) Matrix film tablet for the controlled release of natural mixtures of conjugated oestrogens
US6761907B1 (en) Coated dosage units
CA2382426C (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
US6630166B1 (en) Compositions for conjugated estrogens and associated methods
JPH04210638A (ja) 流体形態で経口投与するための医薬調製物
KR100549625B1 (ko) 프로게스테론 및 에스트로겐을 기재로 하는 피임제 및이것의 제조 방법
NL7909105A (nl) Werkwijze voor het bereiden van een galenisch geneesmiddel.
CA2304331C (en) Coated dosage units
MXPA00002884A (es) Unidades de dosificacion recubiertas
ZA200404083B (en) Pharmaceutical combination of ethinylestradiol anddrospirenone for use as a contraceptive.

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116035

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: N.V. ORGANON

Free format text: N.V. ORGANON